Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ling

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Arthritis Research & Therapy|October 25, 2019
Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factorVictor Farutin, Thomas Prod'homme, Kevin McConnell, et al.
Mabs|February 12, 2025
Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular propertiesNilufer P Seth, Rui Xu, Matthew DuPrie, et al.
Science (New York, N.Y.)|May 29, 2000
Nipah virus: a recently emergent deadly paramyxovirusK B Chua, W J Bellini, P A Rota, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 19, 2008
SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury modelKai Fu, Michael J Corbley, Lihong Sun, et al.
Blood|May 29, 2026
The fetal specific gene LIN28B is essential for human fetal B-lymphopoiesis and initiation of KMT2A::AFF1 infant leukemiaRebecca E Ling, Alia M Welsh, Lucy Hamer, et al.
Cancer Discovery|November 9, 2022
Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic MalignanciesAbdullah O Khan, Antonio Rodriguez-Romera, Jasmeet S Reyat, et al.
NEJM Evidence|January 27, 2026
Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and NewbornDerek P de Winter, Kenneth J Moise, Leona E Ling, et al.
The New England Journal of Medicine|August 8, 2024
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and NewbornKenneth J Moise, Leona E Ling, Dick Oepkes, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Arthritis Research & Therapy|October 25, 2019
Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factorVictor Farutin, Thomas Prod'homme, Kevin McConnell, et al.
Mabs|February 12, 2025
Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular propertiesNilufer P Seth, Rui Xu, Matthew DuPrie, et al.
Science (New York, N.Y.)|May 29, 2000
Nipah virus: a recently emergent deadly paramyxovirusK B Chua, W J Bellini, P A Rota, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 19, 2008
SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury modelKai Fu, Michael J Corbley, Lihong Sun, et al.
Blood|May 29, 2026
The fetal specific gene LIN28B is essential for human fetal B-lymphopoiesis and initiation of KMT2A::AFF1 infant leukemiaRebecca E Ling, Alia M Welsh, Lucy Hamer, et al.
Cancer Discovery|November 9, 2022
Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic MalignanciesAbdullah O Khan, Antonio Rodriguez-Romera, Jasmeet S Reyat, et al.
NEJM Evidence|January 27, 2026
Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and NewbornDerek P de Winter, Kenneth J Moise, Leona E Ling, et al.
The New England Journal of Medicine|August 8, 2024
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and NewbornKenneth J Moise, Leona E Ling, Dick Oepkes, et al.
Pageof 17